Call for Abstract
Scientific Program
17th international conference on Transplantation and Medical Surgery, will be organized around the theme “''Advancing Transplantation and Surgical Excellence for Better Patient Care''”
Transplantation 2026 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Transplantation 2026
Submit your abstract to any of the mentioned tracks.
Register now for the conference by choosing an appropriate package suitable to you.
Xenotransplantation research focuses on the transplantation of genetically engineered animal organs into humans to address the global shortage of donor organs. Current advancements in CRISPR gene editing, immune modulation, organ preservation, and infectious disease prevention are improving graft survival, reducing rejection, and advancing the future of life-saving organ transplantation.
Telemedicine in Post-Surgical Care research focuses on remote patient monitoring, artificial intelligence, wearable health technologies, mobile health applications, and virtual consultations to optimize postoperative recovery. Current advancements enable early detection of complications, improve medication adherence, enhance patient engagement, reduce hospital readmissions, and support personalized follow-up care, leading to better surgical outcomes and improved healthcare accessibility.
Surgical Training and Simulation research focuses on artificial intelligence, virtual reality, augmented reality, robotic simulators, digital twins, and haptic technologies to enhance surgical education and technical proficiency. Current advancements improve procedural accuracy, accelerate skill acquisition, enable competency-based assessment, and strengthen patient safety by providing realistic, risk-free training environments for surgeons across transplantation and complex medical procedures.
Multi-Organ Transplantation research focuses on advanced organ preservation, artificial intelligence–guided donor-recipient matching, precision immunosuppression, ex vivo machine perfusion, and xenotransplantation. Current innovations improve surgical outcomes, reduce graft rejection, optimize allocation strategies, and enhance long-term survival for patients with complex multi-organ failure, advancing the future of personalized transplantation medicine.
AI and Data Analytics in Surgery research focuses on integrating artificial intelligence, machine learning, computer vision, robotic-assisted surgery, predictive analytics, and real-time clinical data to enhance surgical precision and decision-making. Current advancements improve preoperative planning, intraoperative navigation, postoperative risk prediction, and patient outcomes while reducing complications and healthcare costs. These innovations are transforming transplantation and medical surgery through personalized, data-driven, and minimally invasive surgical care.
Organ Donation research focuses on increasing donor availability through advanced donor management, ex vivo organ perfusion, artificial intelligence for donor-recipient matching, public awareness strategies, and ethical policy development. Current advancements improve organ preservation, expand donor eligibility, reduce waiting-list mortality, and enhance successful transplantation outcomes while promoting equitable access to life-saving transplants.
Regenerative Medicine research focuses on stem cell therapies, tissue engineering, 3D bioprinting, gene editing, and biomaterials to repair or replace damaged tissues and organs. Current advancements enhance organ regeneration, improve transplant outcomes, reduce donor organ dependence, accelerate post-surgical healing, and advance personalized treatments in transplantation and reconstructive surgery.
Pediatric Transplantation Advances research focuses on improving long-term outcomes through precision immunosuppression, donor-recipient matching, organ preservation technologies, regenerative medicine, and AI-assisted clinical decision-making. Current innovations enhance graft survival, reduce transplant-related complications, support personalized pediatric care, and improve the quality of life for children requiring life-saving organ transplantation.
Personalized medicine is revolutionizing transplant care by tailoring treatments to individual patient profiles. Genetic testing and biomarker analysis help predict rejection risks and optimize immunosuppressive therapy. This approach enhances graft survival and minimizes adverse effects. Precision medicine allows clinicians to design customized treatment plans, improving patient outcomes.
Laparoscopic Surgery research focuses on minimally invasive surgical techniques enhanced by robotic assistance, artificial intelligence, advanced imaging, fluorescence-guided surgery, and 3D visualization. Current innovations improve surgical precision, reduce postoperative pain, minimize complications, shorten hospital stays, accelerate patient recovery, and optimize outcomes across transplantation, gastrointestinal, urological, gynecological, and general surgical procedures.
nnovations in organ transplantation are improving surgical precision and patient outcomes. Minimally invasive techniques, robotic-assisted procedures, and enhanced preservation methods are transforming transplant success rates. Advances in immunosuppressive therapies reduce rejection risks while maintaining patient safety. Surgeons are increasingly using AI-guided tools for better decision-making during procedures.
Global Innovations in Transplantation research focuses on artificial intelligence, xenotransplantation, regenerative medicine, normothermic machine perfusion, 3D bioprinting, precision immunosuppression, and digital health technologies. Current advancements improve donor organ utilization, reduce graft rejection, enhance long-term transplant outcomes, and expand equitable access to life-saving organ transplantation through personalized, technology-driven approaches.
Transplantation aims to restore organ function and improve survival by replacing diseased or failing organs with healthy donor organs or tissues. Current research focuses on expanding donor availability, improving organ preservation, reducing immune rejection, enhancing long-term graft survival, advancing regenerative medicine, integrating artificial intelligence into transplant care, and developing personalized immunosuppressive therapies to achieve safer, more effective, and accessible transplantation worldwide.
nfection management is critical in transplant recipients due to immunosuppression. Advanced diagnostic tools and preventive strategies help reduce infection risks. Personalized treatment plans and antimicrobial therapies improve patient safety. Monitoring and early detection are essential for managing complications.
The development of artificial organs and bioengineered tissues is transforming transplantation medicine. Innovations in tissue engineering, stem cell research, and biomaterials are creating alternatives to donor organs. These technologies aim to address organ shortages and reduce dependency on donors.
Comprehensive post-transplant care is essential for long-term success. Monitoring patient health, managing medications, and preventing infections are key components. Rehabilitation programs help patients regain strength and improve quality of life. Multidisciplinary care teams ensure holistic support for transplant recipients.
Living donor transplantation offers an effective solution to organ shortages. Advances in surgical techniques ensure donor safety and faster recovery. Careful evaluation and ethical considerations are essential to protect donors’ health and well-being. Improved surgical planning and minimally invasive procedures reduce risks.
Ethical considerations play a vital role in transplantation practices. Issues such as organ allocation, donor consent, and equitable access remain critical concerns. Transparency in organ distribution systems ensures fairness and trust. Addressing illegal organ trade and promoting ethical donation practices are global priorities.
Biomarker research focuses on identifying molecular, genetic, proteomic, metabolomic, and immune signatures for the early detection of organ rejection, infection, and graft dysfunction. Current advancements integrate liquid biopsy, donor-derived cell-free DNA (dd-cfDNA), artificial intelligence, and multi-omics to enable precision monitoring, personalized immunosuppression, improved graft survival, and better long-term transplant outcomes.
Normothermic Machine Perfusion (NMP) is an advanced organ preservation technology that maintains donor organs at normal body temperature using oxygenated blood or a specialized perfusion solution before transplantation. Current research focuses on extending organ preservation time, assessing organ viability in real time, reducing ischemia–reperfusion injury, enabling therapeutic interventions, and expanding the use of marginal donor organs. NMP is transforming liver, kidney, heart, and lung transplantation by improving graft function, increasing transplant success rates, and reducing waiting-list mortality.
Modern surgical practices are evolving with the integration of cutting-edge technologies. Robotic-assisted surgery, 3D imaging, and augmented reality are enhancing precision and reducing complications. These technologies enable surgeons to perform complex procedures with improved accuracy and minimal invasiveness. Enhanced visualization tools and digital platforms support better preoperative planning and intraoperative navigation.
Surgical Precision research focuses on artificial intelligence, robotic-assisted surgery, image-guided navigation, augmented reality, and real-time intraoperative imaging to enhance accuracy during complex procedures. Current advancements improve surgical planning, minimize tissue damage, reduce complications, optimize transplant success, and support personalized, minimally invasive approaches that deliver superior patient outcomes.

